Detalles de la búsqueda
1.
Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: a randomized phase II study of patients with previously untreated HER2-positive metastatic breast cancer.
Breast Cancer Res
; 16(3): R50, 2014 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-24887458
2.
Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study.
J Clin Oncol
; 42(5): 550-561, 2024 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38096461
3.
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trial.
Blood Adv
; 6(14): 4147-4156, 2022 07 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35413116
4.
BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis.
Clin Lymphoma Myeloma Leuk
; 21(4): 267-278.e10, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33303421
5.
MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial.
Leukemia
; 34(2): 522-532, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31462735
6.
Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity.
Mol Cancer Ther
; 7(3): 455-63, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18347133
7.
Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study.
Leuk Lymphoma
; 60(4): 894-903, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30277102
8.
Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma.
Blood Cancer J
; 9(2): 17, 2019 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30718503
9.
AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis.
Clin Cancer Res
; 13(12): 3682-8, 2007 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17575233
10.
Deletion mutants in COP9/signalosome subunits in fission yeast Schizosaccharomyces pombe display distinct phenotypes.
Mol Biol Cell
; 13(2): 493-502, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11854407
11.
Cop9/signalosome subunits and Pcu4 regulate ribonucleotide reductase by both checkpoint-dependent and -independent mechanisms.
Genes Dev
; 17(9): 1130-40, 2003 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12695334
Resultados
1 -
11
de 11
1
Próxima >
>>